Purification of CK1 by affinity chromatography on immobilised axin

Protein Expression and Purification

Volumn 54, Issue 1, 2007, Pages 101-109

  Reinhardt, Jens ^a   Ferandin, Yoan ^a   Meijer, Laurent ^a  

^a STATION BIOLOGIQUE   (France)

Author keywords

Alzheimer's disease; Axin; Cancer; Circadian rhythm; CK1 ; CK1 ; CK1 ; Kinase inhibitors; Protein kinase; Screening

Indexed keywords

AXIN PROTEIN; CASEIN KINASE I; ISOPROTEIN; PEPTIDE; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN LEVEL; CHEMISTRY; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; SWINE;

ANIMALS; BRAIN CHEMISTRY; CASEIN KINASE I; CHROMATOGRAPHY, AFFINITY; ESCHERICHIA COLI; PEPTIDES; PROTEIN ISOFORMS; REPRESSOR PROTEINS; SWINE;

ESCHERICHIA COLI; SUS;

EID: 34247335032     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.02.020     Document Type: Article

References (32)

1. Knippschild U., Gocht A., Wolff S., Huber N., Lohler J., and Stoter M. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal 17 6 (2005) 675-689
2. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., and He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108 6 (2002) 837-847
3. Behrend L., Milne D.M., Stoter M., Deppert W., Campbell L.E., Meek D.W., and Knippschild U. IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene 19 47 (2000) 5303-5313
4. Ghoshal N., Smiley J.F., DeMaggio A.J., Hoekstra M.F., Cochran E.J., Binder L.I., and Kuret J. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Am. J. Pathol. 155 4 (1999) 1163-1172
5. Hastings M.H., Reddy A.B., and Maywood E.S. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 4 8 (2003) 649-661
6. Lee C., Etchegaray J.P., Cagampang F.R., Loudon A.S., and Reppert S.M. Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107 7 (2001) 855-867
7. Zhai L., Graves P.R., Robinson L.C., Italiano M., Culbertson M.R., Rowles J., Cobb M.H., DePaoli-Roach A.A., and Roach P.J. Casein kinase I gamma subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes. J. Biol. Chem. 270 21 (1995) 12717-12724
8. Gietzen K.F., and Virshup D.M. Identification of inhibitory autophosphorylation sites in casein kinase I epsilon. J. Biol. Chem. 274 45 (1999) 32063-32070
9. Rivers A., Gietzen K.F., Vielhaber E., and Virshup D.M. Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle. J. Biol. Chem. 273 26 (1998) 15980-15984
10. Gross S.D., and Anderson R.A. Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signal 10 10 (1998) 699-711
11. Gluecksohn-Schoenheimer S. The effects of a lethal mutation responsible for duplications and twinnings in mouse embryos. J. Exp. Zool. 110 (1949) 47-76
12. Price M.A. CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev. 20 4 (2006) 399-410
13. Luo W., and Lin S.C. Axin: a master scaffold for multiple signaling pathways. Neurosignals 13 3 (2004) 99-113
14. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., and Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 17 5 (1998) 1371-1384
15. Primot A., Baratte B., Gompel M., Borgne A., Liabeuf S., Romette J.L., Jho E.H., Costantini F., and Meijer L. Purification of GSK-3 by affinity chromatography on immobilized axin. Protein Expr. Purif. 20 3 (2000) 394-404
16. Zhang Y., Qiu W.J., Chan S.C., Han J., He X., and Lin S.C. Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways. J. Biol. Chem. 277 20 (2002) 17706-17712
17. Sobrado P., Jedlicki A., Bustos V.H., Allende C.C., and Allende J.E. Basic region of residues 228-231 of protein kinase CK1alpha is involved in its interaction with axin: binding to axin does not affect the kinase activity. J. Cell Biochem. 94 2 (2005) 217-224
18. Rubinfeld B., Tice D.A., and Polakis P. Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon. J. Biol. Chem. 276 42 (2001) 39037-39045
19. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 17 (1997) 3389-3402
20. Zhang J., Gross S.D., Schroeder M.D., and Anderson R.A. Casein kinase I alpha and alpha L: alternative splicing-generated kinases exhibit different catalytic properties. Biochemistry 35 50 (1996) 16319-16327
21. Chijiwa T., Hagiwara M., and Hidaka H. A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis. J. Biol. Chem. 264 9 (1989) 4924-4927
22. Fish K.J., Cegielska A., Getman M.E., Landes G.M., and Virshup D.M. Isolation and characterization of human casein kinase I epsilon (CKI), a novel member of the CKI gene family. J. Biol. Chem. 270 25 (1995) 14875-14883
23. Hidaka H., and Kobayashi R. Protein kinase inhibitors. Essays Biochem. 28 (1994) 73-97
24. Barik S., Taylor R.E., and Chakrabarti D. Identification, cloning, and mutational analysis of the casein kinase 1 cDNA of the malaria parasite, Plasmodium falciparum. Stage-specific expression of the gene. J. Biol. Chem. 272 42 (1997) 26132-26138
25. Mashhoon N., DeMaggio A.J., Tereshko V., Bergmeier S.C., Egli M., Hoekstra M.F., and Kuret J. Crystal structure of a conformation-selective casein kinase-1 inhibitor. J. Biol. Chem. 275 26 (2000) 20052-20060
26. Rena G., Bain J., Elliott M., and Cohen P. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 5 1 (2004) 60-65
27. Yokoyama T., Okano M., Noshita T., Funayama S., and Ohtsuki K. Characterization of (-)-matairesinol as a potent inhibitor of casein kinase I in vitro. Biol. Pharm Bull. 26 3 (2003) 371-374
28. Meijer L., Thunnissen A.M., White A.W., Garnier M., Nikolic M., Tsai L.H., Walter J., Cleverley K.E., Salinas P.C., Wu Y.Z., Biernat J., Mandelkow E.M., Kim S.H., and Pettit G.R. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Chem. Biol. 7 1 (2000) 51-63
29. Gompel M., Leost M., De Kier Joffe E.B., Puricelli L., Franco L.H., Palermo J., and Meijer L. Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum. Bioorg Med. Chem. Lett 14 7 (2004) 1703-1707
30. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 2 (1995) 229-233
31. Godl K., Wissing J., Kurtenbach A., Habenberger P., Blencke S., Gutbrod H., Salassidis K., Stein-Gerlach M., Missio A., Cotten M., and Daub H. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc. Natl. Acad. Sci. USA 100 26 (2003) 15434-15439
32. Iurisci I., Filipski E., Reinhardt J., Bach S., Borradori A.G., Iacobelli S., Meijer L., and Lévi F. improved tumor control through circadian clock induction by Seliciclib, a Cyclin-dependent kinase inhibitor. Cancer Res. 66 22 (2006) 10720-10728